Proton Pump Inhibitor
Pregnancy: C
Omeprazole (Elderly)
Brand names: Losec, Prilosec
Adult dose
Dose: 20–40 mg once daily (treatment); 10–20 mg once daily (maintenance); 20 mg once daily (prevention of NSAID ulcers)
Route: oral or IV
Frequency: once daily
Max: 40 mg/day (oral); 40 mg/day (IV) for Zollinger-Ellison up to 120 mg/day
Take 30–60 min before food for best effect; in elderly: review indication regularly — long-term use without clear indication very common
Paediatric dose
Dose: 0.7 mg/kg
Route: oral
Frequency: once daily
Max: 40 mg/day
Concentration: 10 mg/mL suspension mg/ml
GORD: ≥1 year: 0.7–1.4 mg/kg/day; 1–2 years: 5–10 mg/day; >20 kg: 20 mg/day; H. pylori eradication: 1–2 mg/kg/day
Dose adjustments
Renal
No dose adjustment required
Hepatic
Reduce dose in severe hepatic impairment; max 20 mg/day
Paediatric weight-based calculator
GORD: ≥1 year: 0.7–1.4 mg/kg/day; 1–2 years: 5–10 mg/day; >20 kg: 20 mg/day; H. pylori eradication: 1–2 mg/kg/day
Clinical pearls
- SIGN/NICE: review PPI indication every 6–12 months — >50% of long-term prescriptions in elderly may lack clear indication
- Step-down therapy: H2 antagonist or on-demand PPI for maintenance after healing — reduces long-term risks
- Hypomagnesaemia: check magnesium if on long-term PPI + diuretics/digoxin/QT-prolonging drugs
Contraindications
- Concurrent atazanavir/nelfinavir (pH-dependent absorption)
Side effects
- Headache
- Diarrhoea
- Nausea
- Hypomagnesaemia (long-term)
- Hyponatraemia
- C. difficile (long-term)
- Osteoporosis/fractures (long-term high-dose)
- B12 deficiency (long-term)
Interactions
- Clopidogrel (CYP2C19 — use pantoprazole instead)
- Methotrexate (increases levels)
- Warfarin (increased INR — weak)
- Atazanavir (reduced absorption — CI)
Monitoring
- Magnesium (long-term use)
- B12 (if long-term use >3 years)
- Bone density (if osteoporosis risk)
Reference: BNFc; BNF 86; NICE NG1; SIGN 142. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- SCORE2-OP — 5/10-Year CVD Risk (Age ≥ 70) · Cardiovascular Risk
- SMART Risk Score for Recurrent CVD · Cardiovascular Risk
- IABP Timing Assessment · Mechanical Circulatory Support
- PCSK9 Inhibitor Eligibility Assessment · Lipid Management
- Hearing Handicap Inventory for the Elderly — Screening (HHIE-S) · Hearing
- Clinical Frailty Scale (CFS) · Prognosis
Pathways
- Falls Assessment in Older Adults · NICE CG161 2013
- Delirium Outside ICU · NICE CG103
- Comprehensive Geriatric Assessment (CGA) · BGS / NICE
- Delirium Assessment and Management · NICE CG103 2010
- Frailty Recognition and Management · BGS Frailty Framework / NHS NHSE
- Polypharmacy and Medicines Optimisation · STOPP/START v2 2014 / NICE NG5